Vital Signals, which is developing a direct-to-consumer blood pressure management device, raised $15 million in seed funding, CEO Tom Moss tells Axios Pro exclusively.
What's next: The company plans to start raising $50 million to $100 million in Series A funding shortly, Moss says.
